X4 Pharmaceuticals (XFOR) Tops Q4 EPS by 56c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of $0.29, $0.56 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Barclays sees global expansion intact, warns against market complacency
• Acuity Brands (AYI) Tops Q3 EPS by 15c
• AMC Entertainment closes $200M stock offering, to retire 2027 notes